(Total Views: 613)
Posted On: 11/18/2020 11:05:01 AM
Post# of 145875
NP outlines the issues in a CC and there were initially 3 (if I’m remembering correctly), he then added the receptor occupancy data as another issue a month or so later. The issues were a small discrepancy with syringe packaging, 700mg data, and I don’t recall the third.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)